Morton Collins, Director at INOVIO PHARMACEUTICALS, INC. (INO), bought 20,000 shares at $9.13 ($183K) on 2016-06-28, disclosed to the SEC on 2016-06-29.
Open-market purchase of $183k INO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.13 | 10,000 | $91K | 50.0% |
| 2 | $9.13 | 10,000 | $91K | 50.0% |
| Total | $9.13 avg | 20,000 | $183K | 100% |
| Filing → |
| INO | BUY | 2017-03-28 | $133K | — | Filing → |
| KOPN | BUY | 2016-05-20 | $106K | — | Filing → |
| INO | BUY | 2016-04-18 | $710K | — | Filing → |